Print Page   |   Sign In
Prescribing Buprenorphine Updates from OSBN
Share |


Feb. 3, 2017

Starting this year, nurse practitioners (NPs) and physician assistants (PAs) are eligible to prescribe buprenorphine to treat patients with opioid use disorder. Nurse practitioners interested in prescribing buprenorphine will need to complete 24 hours of Substance Abuse and Mental Health Services Administration (SAMHSA) NP and PA Waiver approved training.
The current 8-hour course is available and delivered in a variety of modalities (combined online and face-to-face or live webinar). For the additional 16 hours, SAMHSA will also offer the training for free through Providers' Clinical Support System for Medication Assisted Treatment once it has been developed.

NPs who meet all the above criteria will then need to independently contact the DEA to update their personal DEA number with the appropriate letter identifier.

However, before NPs in Oregon are able to prescribe Buprenorphine (Suboxone) for medication-assisted-treatment (MAT), the OSBN must approve and adopt language regarding this practice. Currently, it is a violation of the Nurse Practice Act to prescribe  Buprenorphine  for MAT in Oregon.
The Oregon State Board of Nursing (OSBN) will be reviewing Division 56 for proposed language for medication-assisted treatment of opioid use disorder at their Feb. 16, 2017 meeting.


NPO Quarterly Meeting

NPO Pharmacology Conference: Focus on Diabetes

NPO Quarterly Meeting

Privacy Policy

Nurse Practitioners of Oregon, 18765 SW Boones Ferry Road, Suite 200, Tualatin, OR 97062
(503) 293-0011 or 800-634-3552 (Oregon Only) E-mail: